HEPTO - health promotion, training, Minnesota USA
  • HOME
  • About Us
  • COVID-19
  • Programs
    • Emerging Diseases
    • Mental Health
    • Chronic Diseases
    • Women's Health
    • Surgical Services
    • Environment
    • News
    • Gallery
  • Education
    • Library
  • FORMS
  • Donate

Widespread Testing Begins on Malaria Vaccine That Is Only Partly Effective

6/8/2019

0 Comments

 
With malaria deaths rebounding worldwide, a pilot program testing a new and fiercely debated malaria vaccine began on Tuesday in Malawi.
Dr. Katherine O’Brien, the World Health Organization’s director of immunization, called the rollout “a historic moment in the fight against malaria,” and said the testing will soon expand to malarious regions of Ghana and Kenya.
But the vaccine, known as RTS,S, or Mosquirix, has been in development by GSK, the former GlaxoSmithKline, for more than 30 years, and it has serious drawbacks that have led some experts to argue that it does not work well enough to spend millions of dollars pursuing.
Malaria kills about 450,000 people a year, most of them young African children. Over the last 15 years, the death rate has been reduced by more than half through extensive, donor-funded efforts to hand out free mosquito nets, spray homes with insecticide and treat people with a new generation of medicines.
Read More
0 Comments



Leave a Reply.

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    July 2019
    June 2019

    Categories

    All

    RSS Feed

HEPTO

 is a 501 (C)(3) non-profit organization registered and audited in the state of Minnesota.  EIN: 83-0674739
​

Picture
Contact us at 
Info​@hepto.org
(612) 747-6446 
(952) 564-4664
(612) 599-3843

DONATE
Picture
Picture
  • HOME
  • About Us
  • COVID-19
  • Programs
    • Emerging Diseases
    • Mental Health
    • Chronic Diseases
    • Women's Health
    • Surgical Services
    • Environment
    • News
    • Gallery
  • Education
    • Library
  • FORMS
  • Donate